Chebyshev N V, Streliaeva A V, Sadykov V M, Buniatian N D, Sabirov B U, Samylina I A
Med Parazitol (Mosk). 2002 Jan-Mar(1):33-5.
The antimicrobial properties of the drug Cheblin-CK-1 (CCK-1) were determined in mice intraabdominally inoculated with Proteus mirabilis-4691 in a dose of 140-200 million daily cultured microbial bodies. Its comparison agent was ampicillin. CCK-1 was found to act as an antibiotic similar to ampicillin in its effects. The antimicrobial activity of CCK-1 against Staphylococcus aureus and Escherichia coli isolated from the contents of echinococcal cysts from patients operated on was also established. Its echinococcidial activity was found in experiments on the cotton rats and piglets inocculated with echinococci. CCK-1 was also tested on volunteers. Before surgery, 186 patients with echinococcosis took the drug and 26 patients with the same disease did not and they served as controls. At first the drug suppressed the growth of parasitic larvocysts with destruction and death of 85-95% of germinal elements of larvocysts and then killed parasites. In patients receiving a complete course of its therapy, protein and amino acid metabolisms restored, followed by immunity recovery.
对药物Cheblin-CK-1(CCK-1)的抗菌特性进行了测定,实验对象为每日腹腔接种剂量为1.4亿至2亿个培养微生物体的奇异变形杆菌-4691的小鼠。其对照药物为氨苄西林。结果发现CCK-1在作用上类似氨苄西林,具有抗生素作用。还确定了CCK-1对从接受手术的患者棘球蚴囊肿内容物中分离出的金黄色葡萄球菌和大肠杆菌的抗菌活性。在接种棘球蚴的棉鼠和仔猪实验中发现了其抗棘球蚴活性。CCK-1也在志愿者身上进行了测试。手术前,186例棘球蚴病患者服用了该药物,26例同病患者未服用作为对照。起初,该药物抑制寄生幼虫囊肿的生长,使85%至95%的幼虫囊肿生发层细胞遭到破坏和死亡,随后杀死寄生虫。接受其完整疗程治疗的患者,蛋白质和氨基酸代谢得以恢复,随后免疫力也得以恢复。